Seven-year follow-up data of a multicenter, randomized phase 2 study evaluating the treatment of melanoma brain metastases shows ipilimumab plus nivolumab is an effective long-term care option. First ...
Skin cancer advanced clinical practitioners ensure continuity of care for patients with malignant melanoma and other advanced ...
Georgina V. Long, MD, MSc, discussed the long-term follow-up data for the combination of adjuvant dabrafenib and trametinib ...
UZ Leuven and VIB-KU Leuven, in collaboration with Seattle-based Presage Biosciences, are announcing the first patient ...
During a live event, Thach-Giao Truong, MD, moderated a discussion on treating a 78-year-old patient with metastatic melanoma ...
Adding tilsotolimod to ipilimumab did not improve response or survival outcomes in patients with advanced melanoma.
12, 2025 — Metastatic melanoma is the most aggressive form of ... Experimental mRNA Cancer Vaccine Shows Potential for Advanced Stage Cancer Patients in Phase 1 Trial Sep. 13, 2024 — Interim ...
Predictive biomarkers of immunotherapy response are critical for clinical practice. In this study, baseline plasma sCD27 was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback